The regulator has previously approved the mRNA vaccine, SPIKEVAX (elasomeran), in individuals aged six months and older and as a booster dose for adults aged 18 years and older.
TGA grants new provisional approval for Moderna COVID-19 vaccine
October 20, 2022 Latest NewsBioPharmaLatest Video
New Stories
-
Victorian Government slashes funding to cancer treatment alliance
May 10, 2024 - - Latest News -
Neuren reports growing US sales of Australian developed product for Rett syndrome
May 10, 2024 - - Latest News -
Liz Selby named Sanofi's new acting country lead and head of pharma
May 10, 2024 - - Latest News -
Mark Butler highlights listing of medicines for serious heart conditions
May 10, 2024 - - Latest News -
Novartis, Monash University and Monash Health partner for heart health
May 9, 2024 - - Latest News -
New research paper highlights potential but current failings of digital health
May 8, 2024 - - Latest News -
Parliamentary inquiry recommends reforming access arrangements for lobbyists
May 8, 2024 - - Latest News